Status:

WITHDRAWN

Lipodystrophy and Fat Metabolism During Exercise

Lead Sponsor:

University of Exeter

Conditions:

Healthy

Lipodystrophy, Familial Partial

Eligibility:

MALE

18-35 years

Phase:

NA

Brief Summary

Mandibular dysplasia with deafness and progeroid features (MDP) syndrome is a rare genetic metabolic disorder that causes lipodystrophy: the inability of the body to store subcutaneous adipose tissue ...

Detailed Description

During prolonged sub-maximal endurance exercise, both fat and carbohydrate are readily used substrates. The relative contribution and regulation of either is dependent on substrate availability (endog...

Eligibility Criteria

Inclusion

  • SUBJECT WITH FPL
  • Inclusion:
  • • Already known to researchers. Male, 29 years old.
  • CONTROL SUBJECT 1
  • Inclusion:
  • Highly trained, elite-level cyclist (VO2max \> 80 ml/kg/min)
  • Registered with, and racing under the jurisdiction of, British Cycling
  • \~\< 10% of body fat
  • Male
  • 18 - 35 years old
  • Exclusion:
  • Any diagnosed metabolic impairment, as this may affect normal metabolism.
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
  • Chronic use of any prescribed or over-the-counter pharmaceuticals.
  • CONTROL SUBJECT 2
  • Inclusion:
  • Recreationally active, preferably with experience of cycling training.
  • Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP
  • Exclusion:
  • Any diagnosed metabolic impairment, as this may affect normal metabolism.
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.
  • Chronic use of any prescribed or over-the-counter pharmaceuticals.
  • SUBJECT WITH FPL
  • Inclusion:
  • Recreationally active, preferably with experience of cycling training.
  • Similar (± 5 ml⋅kg-1⋅min-1) VO2max¬ to that of the participant with MDP
  • Diagnosis with FPL
  • Exclusion:
  • Female
  • Any diagnosed cardiovascular disease or hypertension to avoid any complications associated with heavy exercise.

Exclusion

    Key Trial Info

    Start Date :

    September 1 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2019

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04056000

    Start Date

    September 1 2019

    End Date

    December 31 2019

    Last Update

    August 31 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    School of Sport and Health Sciences

    Exeter, Devon, United Kingdom, EX4 4JA